A family of nuclear proteins, designated SL3-3 enhancer factors 2 (SEF2), were found to interact with an Ephrussi box-like motif within the glucocorticoid response element in the enhancer of the murine leukemia virus SL3-3. Mutation of the DNA sequence decreased the basal enhancer activity in various cell lines. The important nucleotides for binding of SEF2 are conserved in most type C retroviruses. Various cell types displayed di-fferences both in the sets of SEF2-DNA complexes formed and in their amounts. A cDNA which encoded a protein that interacted specifically with the SEF2-binding sequence was isolated from human thymocytes. The nucleotide sequence specfficity of the recombinant protein, expressed in Escherichia coli, corresponded to that of at least one of the nuclear SEF2 proteins. Sequence analysis of the cDNA revealed that it belongs to the basic helix-loop-helix class of DNA-binding proteins. Several mRNA transcripts of different sizes were identified. Molecular analysis of cDNA clones revealed multiple related mRNA species containing alternative coding regions, which are most probably a result of differential splicing.
Enhancer elements are cis-acting DNA elements which can stimulate transcription in an orientation-and, to some extent, distance-independent manner. Enhancer activity has been shown to result from the integrated function of multiple DNA sequence elements which bind different specific transcriptional activator proteins (for reviews, see references 18, 26, 27, and 43) . Alignment of the enhancers in the long terminal repeats (LTR) of mammalian type C retroviruses has revealed that several sequence motifs are highly conserved (11) . One such conserved domain is a proposed glucocorticoid response element (GRE) (6, 11) . Mutation of this element in Moloney murine leukemia virus both decreased the transcriptional activity in transient assays in cell lines and delayed the latency period of tumor induction in vivo (45, 46) . The murine leukemia virus SL3-3 induces T-cell lymphomas in several strains of mice (40) . An important determinant of the leukemogenicity of SL3-3 has been localized to its LTR (5, 24) . This LTR contains a 72-bp duplicated DNA sequence followed by a third copy of the first 34 bp of the repeat (24) . We have previously shown that the most important DNA sequence elements for the enhancer activity in T lymphocytes are in these repeats (13) . The repeats in the enhancer also contain the conserved GRE motif (6) . However, no or little stimulation of the enhancer activity was seen upon glucocorticoid induction in T lymphocytes, in which the basal enhancer activity is high (7, 13) . In contrast, a strong glucocorticoid effect on the enhancer activity was evident in HeLa cells (7, 13) , in which the basal activity of the enhancer is 6-to 25-fold lower, relative to the simian virus 40 (SV40) enhancer. These results suggest that other transcription factors than the glucocorticoid receptor are interacting with the GRE in lymphoid cells.
In the present report we show that a family of distinct nuclear proteins, designated SL3-3 enhancer factors 2 (SEF2), interact with a sequence within the GRE. The important nucleotide sequences for binding of SEF2 proteins resembled Ephrussi box (E-box) sequences, identified in the * Corresponding author.
immunoglobulin heavy chain and insulin enhancers (10, 33) .
Mutation of the SEF2 sites decreased the basal enhancer activity in various cell types. Three distinct but related human thymocyte cDNAs, denoted SEF2-1A, SEF2-1B, and SEF2-1D, were isolated. Sequence data show that the predicted proteins belong to the basic helix-loop-helix (B-HLH) class of DNA-binding proteins. A segment of one of the cDNAs corresponds to the immunoglobulin transcription factor 2 cDNA, E2-2, shown to encode a transcriptional activator (15) . The DNA sequence recognized by a protein produced in Escherichia coli from SEF2-1A, SEF2-1AP, corresponded to that of at least one of the SEF2 proteins present in nuclear extracts. Several SEF2-1 mRNAs of different sizes were found, and analysis of the SEF2-1 cDNA clones revealed multiple mRNA species containing alternative coding regions, most probably as a result of differential splicing. We conclude that a family of HLH transcriptional activators bind to an E-box motif within the GRE of retrovirus enhancers.
MATERIALS AND METHODS
Bacterial strains, phages, and plasmids. A Xgtll expression library, made from human thymocytes, was purchased from Clonetech. E. coli Y1090 was used for propagation of X phages by following the protocol of Huynh et al. (16) . E. coli MM294 (30) was used for maintenance of plasmids and expression of recombinant protein, and JM103 (31) was used for propagation of M13 phages mp18 and mpl9 (38) . Plasmids pESG53 (13) and pUC19 (52) have been described previously.
Recombinant DNA techniques. Standard recombinant DNA techniques were carried out as described by Maniatis et al. (25) . Transformation of E. coli was performed as described by Hanahan (14) . For DNA sequencing the Sequenase kit (United States Biochemical) was used. All synthetic oligonucleotides were purchased from Symbicom, Umea, Sweden.
Cell lines and cell culture. HeLa, a human carcinoma cell line; X-63 Ag8.653 (denoted in the text as X-63), a nonimmunoglobulin-secreting mouse myeloma (19, 21) ; J558L, a mouse myeloma (39); EL-4, a mouse T-helper cell lymphoma (12, 32) ; BALENTL 13 (denoted in the text as BAL13), a mouse T-helper cell line (20) ; and CTL, a monoclonal cytotoxic T-cell line (2), were grown as previously described (13) .
Nuclear extracts and electrophoretic mobility shift assay.
Preparations of nuclear extracts and the electrophoretic mobility shift assay were performed as previously described (49) . The wild-type DNA segment used as probe in the electrophoretic mobility shift assays was 5'-CCAAGAA CAGATGGTCCCC-3'.
Construction of mutants and transfection assay. The mutant plasmid pESG162 is a derivative of pESG134 (Fig. 1F) (13) . pESG162 harbors a 4-bp substitution at positions 150 to 153 and 294 to 297, from CAGA to ACTC. The mutant plasmid was constructed as previously described (13) . The plasmids have one 72-bp repeat less than the LTR of SL3-3, a deletion that has little effect on the level of transcription in different cell lines (13) . The cotransfected reference plasmid pESGO03 (13) has a structure corresponding to that of pESG134, except that the enhancer is from SV40 and the promoter is from rabbit 3-globin. Lymphocytes and HeLa cells were transfected as previously described (13), by using the DEAE-dextran and calcium phosphate techniques, respectively. RNA was prepared by using the LiCl-urea method, and the specific RNAs were quantified by Si nuclease mapping as previously described (13) .
Screening of the cDNA library. The Agtll cDNA library was screened for expression of DNA-binding proteins by a modified version (51) of a previously published protocol (44) .
The probe used was the KpnI-BamHI fragment with the 72-bp repeats of a plasmid derived from pESG53 ( Fig. 1F ) (13) . This derivative has the 72-bp ApaI fragment multimerized into a total of eight copies of the repeat. This probe and the probe for rescreening by DNA-DNA hybridization (25) were labeled by nick translation.
Expression of SEF2-1A cDNA in E. coli. A derivative of plasmid pESG145 (13), designated pBC03, was constructed by deletion of the NdeI-HindIII restriction fragment. Two annealed synthetic oligonucleotides, which create the sequence 5'-CTCGAGGAAGGAGGCGATTTCTATGGAAT TCGGATCC-3' with a translation start signal, were inserted between the XhoI and BamHI sites of this plasmid. The SEF2-1A cDNA was inserted at the EcoRI site of the synthetic DNA segment. The XhoI-BamHI fragment with the cDNA in the proper orientation was subcloned between the XhoI and BamHI sites of a derivative of the runaway expression plasmid pRCB1 (3), where the 99-bp EcoRI-PstI fragment was replaced by an EcoRI-PstI adapter containing a BamHI restriction site. The final plasmid was denoted pRSEF2. Induction of gene expression from the runaway plasmid has-been described previously (3). Bacteria were harvested and resuspended in a solution containing 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), 0.2 mM EDTA, 420 mM NaCl, 25% glycerol, and the protease inhibitors phenylmethylsulfonyl fluoride (1 mM) , leupeptin (0.5,uglml), pepstatin A (0.7,ug/ml), aprotinin (2,ug/ml), benzamidine (1 mM), soybean trypsin inhibitor (100,ug/ml), antipain (10 mM), and egg white trypsin inhibitor (100,ug/ml). Lysozyme was added to a final concentration of 1 mg/ml, and the cells were incubated at 0°C for 5 min. They were then sonicated three times for 10 s each at 0°C by using a Branson Sonifier on setting 3 with a microtip.
Lysates were centrifuged at maximal speed in an Eppendorf centrifuge for 5 min before use.
Northern (RNA) blot analysis. Total RNA was prepared by using the Nonidet P-40 method (25) , and poly(A)+ mRNA was prepared by using oligo(dT)-cellulose. RNA samples were separated by agarose gel electrophoresis in the presence of formaldehyde (23) , and the RNA was transferred to Hybond-N filters as described previously (48 resulted in more efficient competition of the complexes labeled C in the figure and mutation of the G in segment 13 drastically decreased competition of these complexes, whereas the opposite result was seen for the complex labeled A. The effects of these two mutations provided a basis for dividing the SEF2 proteins into two groups in which the protein(s) responsible for formation of the complex labeled A preferentially binds to palindromes of the sequence 5'-ACA-3', and the protein(s) of complexes labeled C preferentially binds to palindromes of 5'-CCA-3'. Surprisingly, it appeared that both mutation of the central nucleotides to 5'-GC-3' and to 5'-TA-3' improved the DNA binding. It is notable that whereas the SL3-3 sequence is an imperfect inverted repeat, the improved binding sequences are all extending the inverted repeats. In DNA segment 18 the A-to-C mutation in the center of the site were combined, and in segment 19 the mutation improving competition of the C complexes was combined with the same mutation in the center of the site (Fig. 1E ). The combined mutations reproducibly produced clearly stronger competitors than the single mutations for the respective complexes. An overexposed autoradiogram, demonstrating the different efficiencies of these stronger competitors for the A and C types of complexes, is shown in Fig. 1B . The difference between the amounts of A and C complexes was quantified by densitometric scanning in several independent experiments in which different amounts of competitors were used. The ratio between the amounts of the A complex and the upper C complex was on average eightfold lower when DNA segment 18 was used as the competitor than when DNA segment 19 was used. The differences in binding specificities became even more pronounced when DNA segments 18 and 19 were used as labeled probes. The A complex was very dominant compared with the C complexes with labeled DNA segment 18 ( Fig. 1C) , and the C complexes became as abundant as the A complex with DNA segment 19 as the probe (Fig. 1D) . Furthermore, segment 19 could very efficiently compete out the C complexes when segment 18 was used as the probe, and segment 18 could very efficiently compete out the A complex when segment 19 was used as the probe.
The nucleotide sequence specificities of the studied complexes are clearly distinct from the binding specificity of the glucocorticoid receptor, with a reported consensus of 5'-AGAACANNNTGTACC-3' (17) . Thus, the results clearly show that nuclear proteins other than the glucocorticoid receptor bind in vitro to a DNA sequence within the proposed GRE of the SL3-3 enhancer. We designate these proteins SL3-3 enhancer factors 2 (SEF2).
Mutation of the SEF2-binding site decreases basal enhancer activity. We wanted to analyze whether the SEF2 interactions identified in vitro were of significance for activation of transcription from the SL3-3 enhancer in vivo. A plasmid was constructed, pESG162, that carries the SL3-3 enhancer with a mutation in the SEF2/GRE-binding sites in front of the SV40 early promoter (Fig. 1F) . The mutation of the two SEF2/GRE sites of pESG162 consists of four substitutions in a row, from 5'-CAGA-3' to 5'-ACTC-3' (Fig. 1E) , which drastically decreased competition of SEF2 complexes (Fig.  1B) . The mutant plasmid was compared with the corresponding wild-type plasmid, pESG134, in a transient-expression assay. Transcription was quantified in four different cell lines. As shown in Table 1 , the mutation led to a twofold decrease in the basal enhancer activity in all four transfected cell lines. Thus, SEF2 binding appears to regulate the SL3-3 enhancer activity in vivo. Furthermore, addition of the glucocorticoid dexamethasone to HeLa cells showed that the proposed GRE site is mediating the glucocorticoid induction in these cells (Table 1) .
Differential expression of SEF2 proteins in various cell lines and tissues. Expression of SEF2 proteins in various types of cells was analyzed by the EMSA. Nuclear extracts were prepared from the human carcinoma cell line HeLa; two mouse B-cell lines, X-63 and J558L; two mouse T-helper cell lines, EL-4 and BAL13; and CTL, a cytotoxic T-cell line of mouse origin; and tissue derived from the thymus, spleen, and kidney of CBA mice. Competitions were performed with wild-type DNA segment or DNA segment 11, with a singlebase-pair substitution (Fig. 1E) , as a control for the nucleotide sequence specificity of retarded complexes. The analysis resulted in a series of complexes of different mobilities (Fig. 2) . Complexes representing proteins binding with high nucleotide sequence specificity were detected for all nuclear extracts analyzed, but both the set this phage was further tested by probing with several multimerized DNA segments, corresponding to different regions of the SL3-3 enhancer. Only the probe containing the SEF2-binding site hybridized strongly (data not shown). The cDNA insert of the isolated phage was designated SEF2-1A.
DNA-binding specificity of heterologously expressed SEF2-1A. To further investigate the nucleotide sequence specificity of the DNA-binding protein encoded by SEF2-1A, we subcloned the cDNA into a runaway expression plasmid (see Materials and Methods). The cDNA was inserted downstream of a methionine start codon preceded by a ribosomebinding site. Extracts from bacteria carrying this plasmid were analyzed by using the EMSA (Fig. 3 ). An extract from bacteria having the corresponding plasmid without the cDNA insert was used as the control. Figure 3A shows that several retarded complexes of different mobilities were obtained with extracts containing the protein encoded by the SEF2-1A cDNA, designated SEF2-1AP. These complexes could be specifically competed out by the wild-type DNA segment but not by DNA segment 11, carrying a mutation in the SEF2-binding site (Fig. 1E) . Small amounts of noncompetable complexes of high mobility were obtained. These A complexes could represent binding of a bacterial protein, sometimes observed in small amounts when using the control strain, or could represent SEF2-1AP with decreased sequence specificity, perhaps owing to proteolytic degradation or another modification.
The nucleotide sequence specificity of SEF2-1AP was compared with the two sequence specificities found for SEF2 proteins from EL-4 cells, by using competition analysis with the point-mutated DNA segments 2 to 17 described in Fig. 1E . Mutations within the same nucleotide sequence as for SEF2 from the nuclei of EL-4 cells affected binding, but mutations located outside this region did not (cf. Fig. 1A and 3B). Mutation of the C, A, T, and G in segments 7, 8, 11, and 12, respectively, drastically decreased the ability to compete for binding of the wild-type DNA segment. The cloned mRNA encodes a protein with a DNA-binding specificity resembling that of the A type of complex seen with T-cell extracts. Since replacement of the G in segment 13 did not decrease the ability to compete, the nucleotide sequence recognized by the recombinant protein is clearly distinct from that of the proteins responsible for formation of the C type of complex. To analyze the basis for the distribution of mRNA species, we rescreened the cDNA library by DNA-DNA hybridization with the 5' EcoRI-XbaI fragment of SEF2-1A as probe. Three recombinant phages were isolated, and their cDNA inserts, designated SEF2-1B, SEF2-1C, and SEF2-1D, were subcloned into the EcoRI site of pUC19. The complete nucleotide sequences of SEF2-1A and SEF2-1B were determined, as well as the sequences of the parts of SEF2-1C and SEF2-1D which, on the basis of restriction enzyme mapping, differed from the other cDNAs. The nucleotide sequences and the amino acid sequence of the predicted SEF2-1B-encoded protein are shown in Fig. 5 . The cDNA sequences were identical over large stretches. However, a few discrepancies were found. At position 1346 in SEF2-1B a T residue was found instead of the C in the corresponding position in the other three cDNAs. This T would give rise to a stop codon in the otherwise open reading frame of 2,001 bases. We therefore believe that this discrepancy is a cloning artifact.
After position 1836 in SEF2-1B there is a deletion of 12 bp when compared with the other three cDNAs. This 12-bp sequence starts with 5'-GT-3' and ends with 5'-AG-3', which strongly indicates that this deletion is due to the use of an alternative splice site (34) . This has been confirmed by analysis of genomic DNA (unpublished observations). In addition, the first 21 nucleotides of SEF2-1A differ from the corresponding sequence of SEF2-1B and SEF2-1D, and in the same fashion the first 70 nucleotides of SEF2-1D differ from those of SEF2-1B. These differences are also most probably explained by alternative splicing.
The SEF2-1 cDNAs contain a long open reading frame, which for the longest cDNA, SEF2-1B, would encode a predicted protein of 667 amino acids. This reading frame starts at position 200, with an ATG in a suitable context for initiation of translation (22) . This frame is preceded by two in-frame stop codons. These results strongly favor the idea that SEF2-1B contains the complete coding sequence. This coding sequence is preceded by an additional potential translation start codon at position 124. It cannot be excluded that translation starts here, proceeds until the first stop codon in front of the ATG at position 200, and is followed by reinitiation at this start site. It is notable that the 5' untranslated leader has a very high proportion of G C base pairs, 73% .
The open reading frame in SEF2-1B is followed by a 3' noncoding region of 358 bp. An adenosine-rich stretch is found at nucleotides 2375 to 2408, and there is also a stretch of adenosines at the 3' end. SEF2-1A ends in the same stretch of adenosines, and SEF2-1D ends in the preceding adenosine-rich sequence, whereas SEF2-1C is much shorter. No consensus polyadenylation signal was found. It is therefore possible that the initiation of primer elongation during the synthesis of the two cDNAs with the longest 3' extensions occurred at internal A-rich stretches of the mRNA.
SEF2-1 proteins are members of the B-HLH class of DNAbinding proteins. A computer search of the NBRF protein data bank showed that the predicted SEF2-1 proteins contained a 90-amino-acid segment that showed a high homology to the B-HLH DNA-binding domain (35) found in a number of proteins known to be involved in the control of cell growth and differentiation.
DISCUSSION
We have identified a family of proteins, designated SEF2, which interacts with a DNA segment of the 72-bp repeat in the enhancer of SL3-3 virus. The most important nucleotides for binding of SEF2 proteins were 5'-CANNTG-3'. Two groups of complexes could be distinguished, preferentially binding to either 5'-ACANNTGT-3' (A type) or 5'-CCAN NTGQ-3' (C type). The nucleotides surrounding the 8-bp sequences did not appear to be important for the binding.
Mutation of the SEF2-binding site decreased the noninduced enhancer activity twofold in all cell lines tested. This effect on the noninduced level of transcription is clearly significant for the assay method used (see references 13, 37, and 49 and references therein), but it is far from drastic. However, we have previously shown that the SL3-3 enhancer activity results from the integrated function of a large number of sequence elements (13) and that mutations of other individual binding sites for important transcriptional activators have about the same level of effect for the enhancer activity as does the mutation of the SEF2 sites (13, 37, 49) .
The SEF2 site is located within a DNA segment which shows homology to GRE. This DNA segment has previously been attributed to the stimulation of the enhancer by the glucocorticoid dexamethasone in HeLa cells (6, 7, 13, 37) . In this report we demonstrate that the proposed GRE is responsible for the glucocorticoid induction in HeLa cells. We found that the pattern of SEF2-DNA complexes
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SEF2-1B GAGGAAGAGAAGGTGTCCTCGGAGCCTCCCCCTCTCTCCTTGGCCGGCCCACACCCTGGAATGGGAGACGCATCGAATCACATGGGACAGATGTAAAAGGGTCCAAGTTGCCACATTGCT The sequences recognized by the SEF2 proteins resemble E-box sequences found in the immunoglobulin heavy-chain enhancer (10) and in the insulin enhancer (33) . In accordance with this resemblance, the sequence analyses of our isolated SEF2-1 cDNAs show that the predicted proteins contain an amino acid stretch with very high homology to the E12 and E47 proteins in their amino acid stretch which binds to the KE2 E-box in the immunoglobulin enhancer (35) . Thus, the SEF2-1 proteins belong to the B-HLH class of DNA-binding proteins (35) . These proteins include, in addition to E12/E47, the sequence-specific DNA-binding myc family (1); MyoDl, a muscle differentiation protein (9); lyl-J and tal, two genes involved in chromosomal translocations of T-cell leukemias (8, 29) ; and the products of the Drosophila genes daughterless (4), the achaete-scute complex (50), twist (47) , and hairy (42) .
After this study was completed, isolations of cDNAs for two additional B-HLH proteins binding to immunoglobulin enhancer motifs were reported (15) . One of these, E2-2, encoding a protein called immunoglobulin transcription factor 2 by the authors, is a cDNA corresponding to a large segment of one of our cDNAs, SEF2-1B. This cDNA from human B cells is identical to a part of the SEF2-1B sequence from positions 348 to 2383, except that the C at position 1199 is reported to be a T in E2-2. Hence, SEF2-1B most probably represents a full-length cDNA for immunoglobulin transcription factor 2. Henthorn et al. (15) (8, 28, 29) . To analyze the apparently very complex system of different B-HLH proteins in lymphocyte regulation will be of the utmost importance for understanding normal lymphocyte development and leukemogenicity.
